Clinical Trials
3 trialsNCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT02893254 2018-06-04
Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Completed
NCT00085644 2011-04-21
ATLAS
Abbott
Phase 3 Completed